secwatch / observer
8-K filed December 21, 2023, 6:59 PM ET ticker IMUX CIK 0001280776
leadership confidence high sentiment neutral materiality 0.50

Immunic extends CEO, CMO, CSO contracts through Dec 2026 with revised compensation

IMMUNIC, INC.

IMMUNIC, INC. filing history →

Source: SEC EDGAR
accession 0001193805-23-001637
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.